Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of “Real-world” Evidence

IMPORTANCE: Omalizumab is indicated for the management of chronic idiopathic urticaria (CIU) (also known as chronic spontaneous urticaria) in adolescents and adults with persistent hives not controlled with antihistamines. The effectiveness of omalizumab in the real-world management of CIU is largel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Dermatol
Autors principals: Tharp, Michael D., Bernstein, Jonathan A., Kavati, Abhishek, Ortiz, Benjamin, MacDonald, Karen, Denhaerynck, Kris, Abraham, Ivo, Lee, Christopher S.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2018
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439579/
https://ncbi.nlm.nih.gov/pubmed/30427977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2018.3447
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars